Ali Saad Al-shammari: Exploring the Role of SGLT2 Inhibitors After TAVI
Ali Saad Al-shammari, Physician and Cardiology Researcher, shared a post on LinkedIn about recent article he and his colleagues co-authored, published in European Journal of Clinical Pharmacology, adding:
“Proud to share that our systematic review and meta-analysis has been published in the European Journal of Clinical Pharmacology:
‘Therapeutic impact of SGLT2 inhibitors following transcatheter aortic valve implantation:
a GRADE-assessed systematic review and meta-analysis.’
We conducted a PRISMA-guided review of four studies including 12,374 TAVI patients, comparing SGLT2 inhibitors with standard care.
SGLT2 inhibitor therapy was associated with lower:
All-cause mortality: RR 0.62
HF hospitalization: RR 0.67
Myocardial infarction: RR 0.83
Bleeding events: RR 0.81
No significant differences were observed for cardiac death, stroke, pacemaker implantation, or AKI.
While these findings suggest a promising role for SGLT2 inhibitors after TAVI, the evidence remains limited and largely observational. Further randomized trials are needed.
Grateful to all co-authors Khadeeja ali, Yousif Kurmasha, Mohammedsadeq A. Shweliya, Muhammad Shahzaib, Atef Akoum their collaboration.”
Title: Therapeutic impact of SGLT2 inhibitors following transcatheter aortic valve implantation: a grade-assessed systematic review and meta-analysis
Authors: Khadeeja Ali Hamzah, Yousif Hameed Kurmasha, Ali Saad Al-Shammari, Mohammedsadeq A Shweliya, Ali Alsajad Hussein Al-Janabi, Muhammad Shahzaib, Atef Akoum, Yasar Sattar
Stay updated on all scientific advances with Hemostasis Today.
-
May 16, 2026, 14:51Stacey McGeown: Honoured to Host a Rare Bleeding Disorders Event That Meant Everything
-
May 16, 2026, 14:41Sweta Agrawal: Expanding Access to Life-Changing PNH Therapy in Nepal
-
May 16, 2026, 14:23Tom Ferry: ECMO Weaning Begins at the Circuit, Not the Bedside
-
May 16, 2026, 14:18Irina Portier: How Heme-Driven Platelet Signaling Worsens Malaria Neuropathogenesis
-
May 16, 2026, 14:05Amir Sedighi: The Hidden Risk in Global Plasma Supply Strategy
-
May 16, 2026, 13:49Priscilla Chassama: Expanding Healthcare Access for Children Living with Sickle Cell Disease in Geita
-
May 16, 2026, 12:00Anna Oleksiak: Is Thrombocytopenia in Critical Cardiac Care HIT?
-
May 16, 2026, 11:29Kim Gannon: Women Have Unique Stroke Risk Factors and The Warning Signs Can Look Different
-
May 16, 2026, 11:18Maciej Banach: What Is The Optimal Sleep Duration to Reduce Stroke Risk?